Home > Search Results

About - Impetigo

A bacterial skin infection characterized by red sores or blisters that progress to a honey colored crust.

Results: 7

Clear

Impetigo is an itchy and sometimes painful infection of the outer layers of skin. It is especially common in young children. Antibiotics are often used to make it go away faster. Impetigo is highly contagious and caused by bacteria.

Informed Health Online [Internet] - Institute for Quality and Efficiency in Health Care (IQWiG).

Version: August 24, 2017

Research shows that milder cases of impetigo go away faster when they are treated with particular antibiotic creams. It isn't clear whether disinfectant solutions or creams can help.

Informed Health Online [Internet] - Institute for Quality and Efficiency in Health Care (IQWiG).

Version: August 24, 2017

Impetigo causes blister‐like sores. The sores can fill with pus and form scabs, and scratching can spread the infection. Impetigo is caused by bacteria. It is contagious and usually occurs in children. It is the most common bacterial skin infection presented by children to primary care physicians. Treatment options include topical antibiotics (antibiotic creams), oral antibiotics (antibiotics taken by mouth), and disinfectant solutions. There is no generally agreed standard treatment, and the evidence on what intervention works best is not clear.

Cochrane Database of Systematic Reviews: Plain Language Summaries [Internet] - John Wiley & Sons, Ltd.

Version: January 18, 2012

Erysipelas and cellulitis are skin infections that can develop if bacteria enter the skin through cuts or sores. Both infections make your skin swell, and become red and tender. If the right treatment is started early enough, they usually clear up without any lasting effects.

Informed Health Online [Internet] - Institute for Quality and Efficiency in Health Care (IQWiG).

Version: February 22, 2018

People who have already had cellulitis can prevent it from returning by taking low-dose penicillin. When used for this purpose, the penicillin is taken every day for up to twelve months. This preventive treatment is safe and well tolerated.

Informed Health Online [Internet] - Institute for Quality and Efficiency in Health Care (IQWiG).

Version: February 22, 2018

Skin and soft‐tissue infections (SSTIs) are common infections of the skin or the tissue beneath the skin. They include impetigo, abscesses, cellulitis, erysipelas, necrotising (flesh‐killing) skin infections, infections caused by animal or human bites or by animal contact, and infections after surgery.

Cochrane Database of Systematic Reviews: Plain Language Summaries [Internet] - John Wiley & Sons, Ltd.

Version: July 25, 2014

Skin and soft tissue infections such as impetigo, abscesses, ulcers, and surgical site infections are common infections of the skin. For serious skin and soft tissue infections involving the deeper tissues, the death rate and treatment costs are high. Linezolid and vancomycin are antibiotics that are effective in treating skin and soft tissue infections, particularly infections caused by bacteria that have developed resistance to some antibiotics. This review identified nine RCTs, with a total of 3144 participants, and compared treatment with linezolid against treatment with vancomycin for skin and soft tissue infections. No new trials were identified for this first update. Linezolid was found to be more effective than vancomycin for treating these infections. There were fewer skin complications in the group that were treated with linezolid. There were no differences between the two groups in the number of reported deaths, and those treated with linezolid had shorter lengths of hospital stay than those treated with vancomycin. The daily cost of outpatient therapy was less with oral linezolid than with intravenous vancomycin, although for inpatient treatment, linezolid was more expensive than vancomycin. Well‐designed trials will be required in future to confirm these results, as the trials from which these conclusions were drawn were of poor methodological quality, at high risk of bias, and were funded by the pharmaceutical company that makes linezolid.

Cochrane Database of Systematic Reviews: Plain Language Summaries [Internet] - John Wiley & Sons, Ltd.

Version: January 7, 2016

Systematic Reviews in PubMed

See all (26)...

Systematic Review Methods in PubMed

See all (1)...

Recent Activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...